Carlemi Calitz
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Viral Infections and Immunology Research 7
-
- 3D Printing in Biomedical Research 5
- Co-authors
- Chrisna Gouws (9 shared papers)Femke Heindryckx (7 shared papers)Josias H. Hamman (8 shared papers)Nataša Pavlović (5 shared papers)Krzysztof Wrzesinski (6 shared papers)Hans Lennernäs (3 shared papers)Stephen J. Fey (4 shared papers)Pär Gerwins (2 shared papers)
- Journals
- Antiviral Research (3 papers)Cells (2 papers)Expert Opinion on Drug Metabolism & Toxicology (2 papers)Molecules (2 papers)Journal of Visualized Experiments (2 papers)
- Partner nations
- NetherlandsSouth AfricaSweden
In The Last Decade
Carlemi Calitz
24 papers receiving 355 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 42
- Hepatology 31
- Complementary and alternative medicine 19
- Biomaterials 30
- Cancer Research 31
Countries citing papers authored by Carlemi Calitz
This map shows the geographic impact of Carlemi Calitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlemi Calitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlemi Calitz more than expected).
Fields of papers citing papers by Carlemi Calitz
This network shows the impact of papers produced by Carlemi Calitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlemi Calitz. The network helps show where Carlemi Calitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Carlemi Calitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 47 | |
| 2 | 2020 | 44 | |
| 3 | 2015 | 36 | |
| 4 | 2023 | 23 | |
| 5 | 2018 | 20 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 16 | |
| 8 | 2021 | 16 | |
| 9 | 2017 | 15 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 13 | |
| 12 | 2019 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2018 | 12 | |
| 15 | 2024 | 10 | |
| 16 | 2023 | 9 | |
| 17 | 2020 | 9 | |
| 18 | 2015 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2023 | 7 |
About Carlemi Calitz
Carlemi Calitz is a scholar working on Cardiology and Cardiovascular Medicine, Biomedical Engineering, Infectious Diseases, Molecular Biology and Epidemiology, having authored 26 papers that have together received 362 indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (7 papers), Liver physiology and pathology (5 papers), 3D Printing in Biomedical Research (5 papers), Viral gastroenteritis research and epidemiology (3 papers), Mathematical Biology Tumor Growth (2 papers), Cancer Cells and Metastasis (2 papers), Cytomegalovirus and herpesvirus research (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Pharmacology (42 citations), Hepatology (31 citations), Complementary and alternative medicine (19 citations), Biomaterials (30 citations) and Cancer Research (31 citations). Carlemi Calitz has collaborated with scholars based in Netherlands, South Africa and Sweden. Frequent co-authors include Chrisna Gouws, Femke Heindryckx, Josias H. Hamman, Nataša Pavlović, Krzysztof Wrzesinski, Hans Lennernäs, Stephen J. Fey, Pär Gerwins, David Balgoma and Mikael Hedeland. Their work appears in journals such as Antiviral Research, Cells, Expert Opinion on Drug Metabolism & Toxicology, Molecules and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.